Peritoneal Immune System in Patients with Advance Epithelial Ovarian Cancer

被引：12
|
作者：
Wertel, Iwona [1 ]
Nowicka, Aldona [1 ]
Rogala, Ewelina [1 ]
Kotarski, Jan [1 ]
机构：
[1] Med Univ, Chair & Dept Oncol Gynaecol & Gynaecol 1, PL-20950 Lublin, Poland
来源：
INTERNATIONAL REVIEWS OF IMMUNOLOGY | 2011年 / 30卷 / 2-3期
关键词：
ovarian cancer; peritoneal cavity; dendritic cells; tumor-infiltrating cells; ENDOTHELIAL GROWTH-FACTOR; REGULATORY T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; PLASMACYTOID DENDRITIC CELLS; SUPPRESSOR-CELLS; PERIPHERAL-BLOOD; ASCITIC FLUID; IMMUNOSUPPRESSIVE NETWORKS; PROGNOSTIC-SIGNIFICANCE; VASCULAR LEUKOCYTES;
D O I：
10.3109/08830185.2011.569902
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The development of epithelial ovarian cancer is associated with changes in the peritoneal cavity microenvironment. Tumor cells produce different factors, which impairs differentiation, maturation, and function of antigen-presenting cells. In this review, we focus on selected cell populations in the peritoneal cavity immune system and their potential role in epithelial ovarian cancer immunopathogenesis. We devote most attention to dendritic cells because they are considered to be superior in their antigen-presenting ability, compared with both macrophages and B lymphocytes. We also present a brief characterization of tumor-infiltraiting cells in epithelial ovarian cancer patients.
引用
收藏
页码：87 / 101
页数：15
相关论文
共 50 条
  • [21] Peritoneal fluid from ovarian cancer patients stimulates MUC1 epithelial mucin expression in ovarian cancer cell lines
    Munster, DJ
    Quin, RJ
    Bansal, AS
    Ward, BG
    McGuckin, MA
    INTERNATIONAL JOURNAL OF CANCER, 1998, 76 (03) : 393 - 398
  • [22] Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery
    Kumar, Pavan
    Ranmale, Samruddhi
    Tongaonkar, Hemant
    Mania-Pramanik, Jayanti
    VACCINES, 2022, 10 (12)
  • [23] Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
    Macpherson, Anne M.
    Barry, Simon C.
    Ricciardelli, Carmela
    Oehler, Martin K.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 57
  • [24] Emerging immune checkpoint receptors in epithelial ovarian cancer
    Borgstadt, A. D.
    DiSilvestro, P. A.
    Ribeiro, J.
    James, N.
    Emerson, J.
    Oliver, M.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 84 - 84
  • [25] Primary peritoneal cancer: study of 14 cases and comparison with epithelial ovarian cancer
    Fukuda, T.
    Imai, K.
    Yamauchi, M.
    Teramae, M.
    Hashiguchi, Y.
    Ichimura, T.
    Yasui, T.
    Sumi, T.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (01) : 49 - 53
  • [26] Incorporating immune checkpoint inhibitors in epithelial ovarian cancer
    Bogani, Giorgio
    Moore, Kathleen N.
    Ray-Coquard, Isabelle
    Lorusso, Domenica
    Matulonis, Ursula A.
    Ledermann, Jonathan A.
    Gonzalez-Martin, Antonio
    Kurtz, Jean-Emmanuel
    Pujade-Lauraine, Eric
    Scambia, Giovanni
    Caruso, Giuseppe
    Raspagliesi, Francesco
    Colombo, Nicoletta
    Monk, Bradley J.
    GYNECOLOGIC ONCOLOGY, 2025, 193 : 30 - 40
  • [27] Immune biomarkers predictive of survival in epithelial ovarian cancer
    Simons, E.
    Kiet, T.
    Amanam, I.
    Ho, M.
    Fuh, J.
    Fuh, K.
    Kapp, D.
    Odunsi, K.
    Chan, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S45 - S46
  • [28] Survivin Expression as a Prognostic Factor in Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer Treated With Neoadjuvant Chemotherapy
    Gasowska-Bodnar, Agnieszka
    Bodnar, Lubomir
    Dabek, Andrzej
    Cichowicz, Marzena
    Jerzak, Malgorzata
    Cierniak, Szczepan
    Kozlowski, Wojciech
    Baranowski, Wlodzimierz
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (04) : 687 - 696
  • [29] Sorafenib as a third line therapy in patients with epithelial ovarian cancer or primary peritoneal cancer: A phase II study
    Bodnar, Lubomir
    Gornas, Maria
    Szczylik, Cezary
    GYNECOLOGIC ONCOLOGY, 2011, 123 (01) : 33 - 36
  • [30] PEDF promotes tumor dissemination of ovarian cancer cells through an interaction with peritoneal immune system
    Ueno, Sayaka
    Sudo, Tamotsu
    Sugihara, Eiji
    Saya, Hideyuki
    CANCER SCIENCE, 2018, 109 : 334 - 334
12345